Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA testing. In order to conserve the remaining reagent, a controlled process of batch testing was implemented. Therefore, you will likely see additional delays in receiving these supplemental test results.
Read about our plan to mitigate this on the Communications page by clicking this link: Communications
CTS was recently notified that one of the tubes listed in the Sample Acceptability document...
CTS Spotlight at 2018 AABB Annual Meeting Sunday, October 14, 2018 at 1:30 PM: Scientific Oral ...
We sincerely hope to see you at this year’s AABB Annual Meeting in Boston, MA on October 12-16...
In 2016, the Procleix Panther instrument was introduced by Grifols in support of automated NAT ZIKA ...
On August 9, 2019, the new CTS Laboratory Information System was successfully implemented in St...
On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Ris...